Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02259699

NCT02259699
Completed Not Applicable

Who may be able to join

Here is the eligibility information for this clinical trial explained in plain English:

Who might be able to join this trial:

  • You have been diagnosed with stage III ovarian cancer that was treated with surgery to remove as much of the cancer as possible
  • You are a woman aged 21 or older
  • You speak English
  • You are from any ethnic background, including minority groups
  • You may live in a city or a rural area

Who may not be able to join:

  • Men are not eligible, as this trial is specifically for ovarian cancer patients
  • Women under the age of 21 are not eligible for this trial
  • People who do not speak English are not eligible (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University of California, Irvine
Registry
clinicaltrials_gov
Start date
1 December 2014
Est. completion
31 December 2016

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Satisfaction With Decision; Decisional Regret

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov